Claudio Laudani: We Summarize Current Knowledge and Future Perspectives On The Role of Inflammation in Patients with MI
Claudio Laudani, Cardiovascular Disease Fellow UNICT, Post-Doc Research Scholar UFHealth JAX, shared on LinkedIn:
”Inflammation is a key driver of ischemic heart disease and myocardial infarction, having a central role in both the arterial wall and myocardial tissue.
Recently, novel approaches have reignited the interest in anti-inflammatory strategies after acute myocardial infarction.
However, key knowledge gaps remain regarding potential class effects, drug choice, patient selection, and the optimal administration timing.
In this state of the art review, we summarize current knowledge and future perspectives on the role of inflammation in patients with myocardial infarction, as well as potential targets and pharmacological treatments being currently under development.”
Read the full article in JACC.
Article: Targeting Inflammation After Acute Myocardial Infarction
Authors: Antonino Imbesi, Antonio Greco, Marco Spagnolo, Claudio Laudani, Carmelo Raffo, Simone Finocchiaro, Placido Maria Mazzone, Davide Landolina, Maria Sara Mauro, Luigi Cutore, Giacinto Di Leo, Denise Cristiana Faro, Nicola Ammirabile, Daniele Giacoppo, Davide Capodanno
Stay updated on all scientific advances in the field of thrombosis with Hemostasis Today.
-
Jan 12, 2026, 04:51Coronary Microvascular Dysfunction and HFpEF․ Prognostic Importance and Therapeutic Insights
-
Jan 12, 2026, 04:16Wolfgang Miesbach on VTE and Cancer: A 20-Year Signal That Can’t Be Ignored
-
Jan 12, 2026, 03:54Francine Freitas Fernandes on Transvaginal US for Pelvic Venous Disorders
-
Jan 12, 2026, 02:58Jara Garcia Ugaldebere Shares STORM-PE Results: Thrombectomy Plus Anticoagulation for Acute High-Risk PE
-
Jan 12, 2026, 02:54Discover the New Blood Project․ Enhanced Search, Browsing, and Learning Resources
-
Jan 12, 2026, 02:54Can Preoperative Iron Status Predict Severe Anemia After Bariatric Surgery?
-
Jan 12, 2026, 02:27Bryce Kerlin to Impact of Advanced Hemostasis/Thrombosis Fellowship Training at Haemophilia Publication
-
Jan 12, 2026, 02:21Martin Haluzík on Compariosn of Cardiovascular Outcomes Between Semaglutide and Dulaglutide Therapies
-
Jan 12, 2026, 01:55Frank Weinz on State-of-the-Art Thromboembolism Prophylaxis